Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.851 | 0.200 | 17 | 58695008 | stop gained | -/A | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 4 | 2010 | 2016 | ||||||||
|
0.851 | 0.200 | 17 | 58695008 | stop gained | -/A | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Endocrine System Diseases | 0.700 | 1.000 | 4 | 2010 | 2016 | ||||||||
|
0.851 | 0.200 | 17 | 58695008 | stop gained | -/A | delins |
|
0.700 | 1.000 | 4 | 2010 | 2016 | |||||||||
|
0.851 | 0.200 | 17 | 58695008 | stop gained | -/A | delins |
|
0.700 | 1.000 | 3 | 2010 | 2016 | |||||||||
|
17 | 58696719 | frameshift variant | -/A | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | |||||||||||||
|
0.851 | 0.200 | 17 | 58695008 | stop gained | -/A | delins |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 17 | 58695174 | frameshift variant | -/A | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | ||||||||||||
|
1.000 | 17 | 58695174 | frameshift variant | -/A | delins |
|
0.700 | 0 | |||||||||||||
|
17 | 58694983 | stop gained | -/AATG | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | |||||||||||||
|
0.925 | 0.120 | 17 | 58696811 | frameshift variant | -/C | delins |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
0.925 | 0.120 | 17 | 58696811 | frameshift variant | -/C | delins |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
17 | 58696787 | frameshift variant | -/TA | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | |||||||||||||
|
1.000 | 17 | 58724097 | frameshift variant | A/- | delins |
|
0.700 | 1.000 | 1 | 2003 | 2003 | ||||||||||
|
17 | 58709972 | frameshift variant | A/- | delins | 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | ||||||||||||
|
1.000 | 17 | 58724043 | frameshift variant | A/- | delins |
|
0.700 | 0 | |||||||||||||
|
1.000 | 17 | 58724097 | frameshift variant | A/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | ||||||||||||
|
1.000 | 17 | 58724038 | splice acceptor variant | A/- | del | 7.0E-06 |
|
0.700 | 0 | ||||||||||||
|
1.000 | 17 | 58724038 | splice acceptor variant | A/- | del | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | |||||||||||
|
0.882 | 0.120 | 17 | 58709857 | splice acceptor variant | A/C;G | snv | 2.0E-05 | 2.1E-05 |
|
0.700 | 1.000 | 11 | 2010 | 2016 | |||||||
|
0.882 | 0.120 | 17 | 58709857 | splice acceptor variant | A/C;G | snv | 2.0E-05 | 2.1E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 6 | 2011 | 2016 | ||||||
|
1.000 | 17 | 58724038 | splice acceptor variant | A/C;G | snv | 1.2E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 4 | 2013 | 2016 | ||||||||
|
0.882 | 0.120 | 17 | 58709857 | splice acceptor variant | A/C;G | snv | 2.0E-05 | 2.1E-05 |
|
0.700 | 1.000 | 2 | 2013 | 2015 | |||||||
|
1.000 | 17 | 58724038 | splice acceptor variant | A/C;G | snv | 1.2E-05 |
|
0.700 | 1.000 | 2 | 2013 | 2016 | |||||||||
|
0.882 | 0.120 | 17 | 58709857 | splice acceptor variant | A/C;G | snv | 2.0E-05 | 2.1E-05 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | |||||||||
|
1.000 | 17 | 58734116 | splice acceptor variant | A/G | snv |
|
0.700 | 1.000 | 4 | 2010 | 2015 |